Prasad Parmeshwaran Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

NEW YORK--(BUSINESS WIRE)--Lazard Ltd (NYSE: LAZ) announced today that Prasad Parmeshwaran has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran primarily advises clients on financial matters in the biotechnology and diagnostics sectors.

“We welcome Prasad, who brings nearly two decades of advising healthcare clients, particularly in biotechnology and diagnostics M&A,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “He joins our well-established team on the West Coast, bolstering our presence advising on private and public strategic transactions.”

Prior to joining Lazard, Mr. Parmeshwaran was a Managing Director at Cowen Inc. where he built and oversaw the firm’s Healthcare M&A group since 2016. Earlier in his career he held investment banking roles in the healthcare group at Goldman Sachs, where he worked for 10 years. Mr. Parmeshwaran obtained his postgraduate diploma in management from the Indian Institute of Management, and his M.B.A. from the New York University Stern School of Business.

About Lazard

Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ-FAPE